These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preferences for health outcomes and cost-utility analysis. Torrance GW Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342 [TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients. Lloyd AJ; Kerr C; Penton J; Knerer G Value Health; 2015 Dec; 18(8):1152-7. PubMed ID: 26686802 [TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in early breast cancer. Groenvold M Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024 [TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients with melanoma expressed as utilities and disability weights. Tromme I; Devleesschauwer B; Beutels P; Richez P; Leroy A; Baurain JF; Cornelis F; Bertrand C; Legrand N; Degueldre J; Thomas L; Legrand C; Lambert J; Haagsma J; Speybroeck N Br J Dermatol; 2014 Dec; 171(6):1443-50. PubMed ID: 25039853 [TBL] [Abstract][Full Text] [Related]
6. [Study on medical economic evaluation methods for metastatic brain tumors therapy]. Takura T; Hayashi M; Muragaki Y; Iseki H; Uetsuka Y No Shinkei Geka; 2010 Jul; 38(7):629-37. PubMed ID: 20628189 [TBL] [Abstract][Full Text] [Related]
7. Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied? Matter-Walstra K; Klingbiel D; Szucs T; Pestalozzi BC; Schwenkglenks M Pharmacoeconomics; 2014 Jun; 32(6):591-9. PubMed ID: 24671924 [TBL] [Abstract][Full Text] [Related]
8. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458 [TBL] [Abstract][Full Text] [Related]
9. [Valuation of health-related quality of life and utilities in health economics]. Greiner W; Klose K Z Evid Fortbild Qual Gesundhwes; 2014; 108(2-3):120-5. PubMed ID: 24780709 [TBL] [Abstract][Full Text] [Related]
10. Estimation of the relationship between body mass index and EQ-5D health utilities in individuals with type 2 diabetes: evidence from the population-based KORA studies. Hunger M; Schunk M; Meisinger C; Peters A; Holle R J Diabetes Complications; 2012; 26(5):413-8. PubMed ID: 22699110 [TBL] [Abstract][Full Text] [Related]
11. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
12. [Health Status of the German population: results of a representative survey using the EuroQol questionnaire]. König HH; Bernert S; Angermeyer MC Gesundheitswesen; 2005 Mar; 67(3):173-82. PubMed ID: 15789280 [TBL] [Abstract][Full Text] [Related]
13. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis. Lillegraven S; Kristiansen IS; Kvien TK Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285 [TBL] [Abstract][Full Text] [Related]
15. The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. Cohn DE; Ko E; Meyer LA; Wright JD; Temkin SM; Foote J; Jones NL; Havrilesky LJ Gynecol Oncol; 2017 Apr; 145(1):185-191. PubMed ID: 28258763 [No Abstract] [Full Text] [Related]
16. Responsiveness of EQ-5D utility indices in alcohol-dependent patients. Günther OH; Roick C; Angermeyer MC; König HH Drug Alcohol Depend; 2008 Jan; 92(1-3):291-5. PubMed ID: 17888587 [TBL] [Abstract][Full Text] [Related]
17. Systematic overview of cost-utility assessments in oncology. Earle CC; Chapman RH; Baker CS; Bell CM; Stone PW; Sandberg EA; Neumann PJ J Clin Oncol; 2000 Sep; 18(18):3302-17. PubMed ID: 10986064 [TBL] [Abstract][Full Text] [Related]
18. The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease. Leidl R; Reitmeir P; König HH; Stark R Value Health; 2012 Jan; 15(1):151-7. PubMed ID: 22264983 [TBL] [Abstract][Full Text] [Related]
19. Italian population-based values of EQ-5D health states. Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG Value Health; 2013; 16(5):814-22. PubMed ID: 23947975 [TBL] [Abstract][Full Text] [Related]
20. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol. Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F; Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]